NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 142 filers reported holding NEVRO CORP in Q1 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $18,334,000 | -14.9% | 229,608 | -7.7% | 1.04% | -13.1% |
| Q1 2018 | $21,552,000 | +1.1% | 248,673 | -19.5% | 1.20% | +17.6% |
| Q4 2017 | $21,321,000 | -38.8% | 308,819 | -19.4% | 1.02% | -28.1% |
| Q3 2017 | $34,829,000 | -14.8% | 383,247 | -30.2% | 1.42% | +8.6% |
| Q2 2017 | $40,857,000 | -18.2% | 548,935 | +3.0% | 1.30% | -22.3% |
| Q1 2017 | $49,940,000 | +55.9% | 532,983 | +20.9% | 1.68% | +61.6% |
| Q4 2016 | $32,030,000 | -35.1% | 440,818 | -6.8% | 1.04% | -19.0% |
| Q3 2016 | $49,371,000 | +25.5% | 472,940 | -11.3% | 1.28% | +26.7% |
| Q2 2016 | $39,341,000 | -35.8% | 533,364 | -51.0% | 1.01% | +28.5% |
| Q1 2016 | $61,278,000 | +130.0% | 1,089,180 | +176.0% | 0.79% | +23.4% |
| Q4 2015 | $26,641,000 | +45.5% | 394,636 | +0.0% | 0.64% | +46.3% |
| Q3 2015 | $18,307,000 | -13.8% | 394,635 | -0.2% | 0.44% | -3.3% |
| Q2 2015 | $21,248,000 | +249.0% | 395,311 | +211.2% | 0.45% | +229.2% |
| Q1 2015 | $6,089,000 | – | 127,038 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
| Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
| Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
| ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
| TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
| Venator Management LLC | 25,000 | $480,500 | 0.18% |
| DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
| FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
| Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |